The first-in-human clinical study of SRP-1005, known as INSIGHTT, is expected to begin in the second quarter of 2026CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the ...
Independent Newspaper Nigeria on MSN
Oyedepo charges Covenant University staff on excellence, spirituality at resumption assembly
Covenant University Pro-Chancellor, Pastor (Mrs) Faith Oyedepo, has urged faculty and staff to uphold excellence and spirituality as the institution begins a new academic year.The Pro-Chancellor of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results